Method for promoting mesenchymal stem and lineage-specific cell proliferation
AssigneeUniversity of Southern Cailfornia
InventorsKathleen E. Rodgers, Gere DiZerega
Life of this patent
Estimating the term…
Abstract
The present invention fulfills a need in the art for methods that promote hematopoietic and mesenchymal stem and lineage-specific cell proliferation and differentiation by growth in the presence of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII), AII analogues, AII fragments and analogues thereof and AII AT2 type 2 receptor agonists.
Claims12
A method of accelerating the proliferation of mesenchymal stem and lineage specific cells comprising contacting the mesenchymal stem and lineage-specific cells with an amount effective to accelerate proliferation of the mesenchymal stem and lineage-specific cells of at least one active agent comprising a sequence of at least six contiguous amino acids of groups R1-R8 in the sequence of general formula I
- R1-R2-R3-R4-R5-R6-R7-R8
- wherein RA is selected from the group consisting of H, Asp, Glu, Asn, 1-aminocyclopentane carboxylic acid, Ala, N,N-dimethylglycyl, Pro, 1-carboxy-N,N,N-trimethylmethanaminium hydroxide inner salt, Glu(NH2), Gly, Asp(NH2) and Succinyl, or is absent;
- wherein RB is selected from the group consisting of Arg, Lys, Ala, Orn, Ser(Ac), Sar, D-Arg and D-Lys;
- R3 is selected from the group consisting of Val, Ala, Leu, Nle, Ile, Gly, Pro, Aib, Acpc and Tyr;
- R4 is selected from the group consisting of Tyr, diphospho tyrosine, Thr, Ser, homoserine and aza-α′-homo-L-tyrosyl;
- R5 is selected from the group consisting of Ile, Ala, Leu, Nle, Val and Gly;
- R6 is selected from the group consisting of His, Arg and 6-NH2-Phe;
- R7 is selected from the group consisting of Pro and Ala;
- and
- R8 is selected from the group consisting of Phe, p-bromo-L-phenylalanyl, Ile and Tyr.
Dependencies are inferred from the claim text.